A box of Ozempic, a semaglutide injection drug used for treating type 2 diabetes and made by Novo Nordisk, is seen at a Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. REUTERS/George Frey/File Photo
Ad RAD Intel
The Company Fixing Ads Isn't Public Yet – But Insiders Are Investing
You've seen them. The cringey, mistargeted, and downright WTF ads. You sit there wondering why brands are spending billions on content that just leaves you questioning your entire algorithmic existence after seeing it.
RAD Intel is teaching brands - with proprietary tech - how to read the room. Their AI helps brands understand why content works, who it actually resonates with, and what to say next. RAD analyzes real-time audience behavior and predicts what will convert, so brands can stop guessing and start making ads that actually land.
And it's already in serious demand. Fortune 1000 brands like Hasbro, Sweetgreen, Skechers, and MGM are using RAD Intel to level up their marketing - and getting up to 3.5x better results. With $37M+ raised and a valuation that's jumped from $5M to $85M*, it's a bit of a shock that RAD Intel is still pre-IPO. Shares are just $0.60, and investors from Meta, Google, Amazon, and Fidelity Ventures are already in.
So check them out now and get in on the action before then, lest you get stuck in the "I almost invested" cycle of regret.
Click here to secure your shares
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.